<DOC>
	<DOCNO>NCT00412971</DOCNO>
	<brief_summary>The main objective study compare 1-year recurrence rate Hexvix assist Transuretheral Resection Bladder ( TURB ) standard white light TURB patient suspicion non-invasive bladder cancer . The hypothesis test whether 1-year recurrence rate different Hexvix assist TURB compare standard white light TURB .</brief_summary>
	<brief_title>A Randomized , Comparative Study Hexvix Fluorescence Cystoscopy Standard Cystoscopy Patients With Non-invasive Bladder Cancer</brief_title>
	<detailed_description>The main objective study compare 1-year recurrence rate Hexvix assist Transuretheral Resection Bladder ( TURB ) standard white light TURB patient suspicion non-invasive bladder cancer . Patients follow 4 , 8 12 month initial TURB . This follow-up regimen accord standard clinical practice Denmark . Recurrence non-invasive bladder cancer frequent , study design investigate whether Hexvix assist TURB reduce early recurrence compare standard TURB</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<criteria>Patients suspicion noninvasive bladder cancer indicate transuretheral resection bladder Above 18 year Written inform consent obtain Gross hematuria . ( Note : Gross hematuria define heavy bladder bleed result marked amount blood urine , may interfere fluorescence cystoscopy . Where bleed light , patient exclude investigator 's opinion , rinse cystoscopy alleviate possible interference fluorescence cystoscopy ) . Patient porphyria . Known allergy hexyl aminolevulinate hydrochloride similar compound . Participation clinical study investigational drug either concurrently within last 30 day . Pregnant breastfeeding ( woman childbearing potential must document negative serum urine pregnancy test screening use contraceptive pill intrauterine device ( IUD ) treatment least one month thereafter ) . Conditions associate risk poor protocol compliance .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Recurrence bladder cancer</keyword>
	<keyword>Fluorescence cystoscopy</keyword>
</DOC>